Neurotoxicity Syndromes: all 139 studies
Page 1 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Microbiome Determinants of Adverse Effects of Stereotactic RadiosurgeryRecruitingNCT07767981
- Delayed Toxicities Post-CAR-TRecruitingNCT07665307
- Extracellular Vesicles and Chemotherapy-Induced Peripheral NeuropathyRecruitingNCT07558447Not applicable
- Assessing DCog Short for Neurotoxicity in CAR-TRecruitingNCT07403812Not applicable
- Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint InhibitorsRecruitingNCT07357636
- Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T TherapyRecruitingNCT07173166Not applicable
- Nerve Excitability in Cisplatin-Induced Peripheral NeuropathyRecruitingNCT07095998Not applicable
- Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)Enrolling by invitationNCT06950190Phase 3
- Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1RecruitingNCT06649474Not applicable
- ADC-induced Neurotoxicity Treated With DuloxetineRecruitingNCT06551051Phase 2
- A Pilot Study for Pupillary Assessment to Predict CAR-T Related NeurotoxicityRecruitingNCT06144151
- Effects of Lead Exposure on Ferroptosis PathwayRecruitingNCT05950386
- Influence of General Anesthesia on the Dynamic Changes in Brain Damage Markers During and After Craniosynostosis Operations in InfancyEnrolling by invitationNCT05911139
- Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXELRecruitingNCT05695313Phase 2
- Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity SyndromeRecruitingNCT05643092
- Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release FormulationsRecruitingNCT05089604Phase 4
- Chemotherapy Induced Peripheral Neurotoxicity (CIPN): Why Should we CareRecruitingNCT04986891
- Effect of Antibiotic Choice On ReNal Outcomes (ACORN)CompletedNCT05094154Phase 4Results posted
- A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated NeurotoxicityCompletedNCT04150913Phase 2Results posted
- A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated NeurotoxicityTerminatedNCT03954106Phase 2Results posted
- Envarsus Neurotoxicity Burden in Liver Transplant PatientsCompletedNCT03823768Phase 4Results posted
- Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell LymphomaActive, not recruitingNCT03696784Phase 1Results posted
- Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant RecipientsCompletedNCT03461445Phase 4Results posted
- Biomarkers in Chemotherapy-Induced Peripheral NeurotoxicityCompletedNCT03348956Not applicableResults posted
- Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCompletedNCT02311907Phase 3Results posted
- Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based RegimenCompletedNCT01978743Not applicableResults posted
- Haloperidol and Lorazepam for Delirium in Patients With Advanced CancerActive, not recruitingNCT01949662Phase 2Results posted
- Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D PathwayTerminatedNCT01499940Phase 2Results posted
- Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System LymphomaCompletedNCT01399372Phase 2Results posted
- Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain TumorCompletedNCT01381718Phase 2Results posted
- Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By SurgeryCompletedNCT01372774Phase 3Results posted
- Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT01279681Phase 3Results posted
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination ChemotherapyCompletedNCT01099449Phase 3Results posted
- Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by ChemotherapyCompletedNCT00952848Phase 2Results posted
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial CancerStatus unknownNCT00807768Phase 3Results posted
- Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple MyelomaCompletedNCT00792142Phase 2Results posted
- S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing ChemoCompletedNCT00775645Phase 3Results posted
- L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast CancerTerminatedNCT00754767Phase 4Results posted
- Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid TumorsCompletedNCT00566852Phase 3Results posted
- Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerCompletedNCT00489411Phase 3Results posted
- Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer PatientsCompletedNCT00471445Phase 3Results posted
- Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the BrainCompletedNCT00452868Early Phase 1Results posted
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With CancerCompletedNCT00369564Phase 3Results posted
- Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid TumorsCompletedNCT00365768Phase 2Results posted
- Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for CancerCompletedNCT00363129Phase 3Results posted
- Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By SurgeryCompletedNCT00316914Phase 3Results posted
- D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic PainTerminatedNCT00301080Phase 3Results posted
- Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerCompletedNCT00068445Phase 3Results posted
- EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast CancerCompletedNCT00046891Phase 3Results posted
- o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate CancerCompletedNCT07333976Phase 2
- Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC PatientsCompletedNCT07320950Phase 3
- Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat PoisoningActive, not recruitingNCT06798142
- Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMMWithdrawnNCT06352866Phase 2
- CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.CompletedNCT05942872
- Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral NeurotoxicityStatus unknownNCT05834231Phase 1/2
- Electro-acupuncture for the Prevention and Treatment of Oxaliplatin-induced Neurotoxicity in Colorectal Cancer PatientsStatus unknownNCT05798884Not applicable
- Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10CompletedNCT05648526Not applicable
- HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BCStatus unknownNCT05566457Phase 2
- Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity SyndromeCompletedNCT05510596Not applicable
- the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving OxaliplatinStatus unknownNCT05494320
- Biomarkers for Chemotherapy Associated NeurotoxicityStatus unknownNCT05280262Not applicable
- EEG Encephalopathy Patterns in Immune Effectors Cells-associated Neurotoxicity Syndrome (ICANS)Lay LanguageCompletedNCT05040230
- Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based ChemotherapyCompletedNCT05025826Not applicable
- Serum Neurofilament Light (NfL) as a Marker for Brain Injury in Individuals Undergoing Chimeric Antigen Receptor-modified T TherapyTerminatedNCT04614987
- Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)CompletedNCT04583124Not applicable
- GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound PaclitaxelWithdrawnNCT04538833Phase 2
- Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-CelActive, not recruitingNCT04514029Early Phase 1
- Compression Gloves to Reduce Albumin-binding Paclitaxel Induced Peripheral Sensory and Motor Neurotoxicity (REMAINING)Status unknownNCT04446819Not applicable
- Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/behavioral Assessment Results in ChildrenActive, not recruitingNCT04364945Not applicable
- Neurotoxicity of Anesthesia in Middle Aged PatientsStatus unknownNCT04275531
- Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile NeutropeniaStatus unknownNCT04250038
- A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel NeurotoxicityCompletedNCT04222790Phase 2
- Ivermectin Neurotoxicity and ABCB1 Gene MutationsCompletedNCT04174469
- Anesthetic Neurotoxicity: the Association Between General Anesthesia and the Level of Plasma Neurofilament LightStatus unknownNCT04164329
- ONSD and Neurotoxicity in Liver TransplantCompletedNCT03799770
- Evaluation of Neurotoxic Effect of Sevoflurane-Based AnaesthesiaGuided by Short-Term Olfactory IdentificationCompletedNCT03726580
- A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)CompletedNCT03685500Phase 4
- Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk FactorsCompletedNCT03628300
- Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia PatientsCompletedNCT03593304Phase 2/3
- Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 YearsCompletedNCT03561168
- Clinical Trial of Electroacupuncture Stimulation on Prevention and Treatment of Oxaliplatin NeurotoxicityStatus unknownNCT03330964Not applicable
- Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid HemorrhageCompletedNCT03213392
- Cassava Intervention ProjectCompletedNCT03157336Not applicable
- A Study to Compare the Long-term Outcomes After Two Different AnaestheticsActive, not recruitingNCT03089905Phase 3
- A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM StudyCompletedNCT03067285Phase 4
- Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric CancerStatus unknownNCT02577263
- Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer PatientsStatus unknownNCT02500810Phase 2
- Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal CancerCompletedNCT02486198Phase 3
- To Study the Individual Variants of Chemotherapy-Induced NeurotoxicityActive, not recruitingNCT02481336
- Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast CancerCompletedNCT02468739Phase 3
- Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective StudyStatus unknownNCT02309242Not applicable
- Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric CancerStatus unknownNCT02024438Phase 3
- Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRCStatus unknownNCT02024412Phase 3
- Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyCompletedNCT01982591
- Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)CompletedNCT01894347
- Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC PatientsStatus unknownNCT01882621Phase 3
- Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast CancerCompletedNCT01763710Phase 2
- Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing ChemotherapyWithdrawnNCT01492920Phase 3
- Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT01445288
- Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk NeuroblastomaCompletedNCT01418495